<DOC>
	<DOCNO>NCT00679965</DOCNO>
	<brief_summary>The purpose study determine safety efficacy 2.5 % , 5.0 % , 7.5 % AN2690 Solutions compare vehicle alone treatment distal , subungual onychomycosis great target toenail .</brief_summary>
	<brief_title>Study Different Doses Novel Treatment Onychomycosis</brief_title>
	<detailed_description>The intent subject complete 180 day treatment period consist 90 consecutive day daily treatment assign study treatment follow additional 90 day three time weekly dosing , even treat toenail ( ) evaluate `` complete responder '' prior end treatment 180 day treatment period . At end 180-Day treatment period , subject remain study classify complete responder , partial responder , non-responders . All complete partial responder continue follow additional 180 day last evaluation inclusion final analysis . Periodic efficacy local tolerance evaluation test medication perform target great toenail treat toenail . KOH wet mount fungal culture treatment-targeted great toenail perform schedule . Subjects also query adverse event evaluate application site reaction . Clinical laboratory assessment safety make Screening , periodically throughout study , upon premature discontinuation study .</detailed_description>
	<mesh_term>Onychomycosis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Tavaborole</mesh_term>
	<criteria>1 . Witnessed , sign informed consent approve Institutional Review Board/Ethics Committee . 2 . Male female subject race least 18 year age old 65 year age . 3 . Subjects diagnosis onychomycosis least one great toenail positive KOH wet mount positive fungal culture dermatophyte . 4 . Onychomycosis involve 2060 % affect great toenail determine baseline ( Day 1 ) visual inspection nail trim . 5 . The combined thickness distal nail plate associate hyperkeratotic nail bed &lt; 3 mm . 6 . Affected great toenail treat capable regrowth document history recent observation least 2 mm growth . 7 . Normal clinically significant screen safety lab . 1 . Females childbearing potential use highly effective method birth control ( e.g . implant , injectables , combine oral contraceptive , intrauterine contraceptive device ) study . 2 . Diabetes mellitus require treatment diet exercise . 3 . Subjects chronic moccasin type T. pedis . 4 . Subjects history fail previous topical antifungal therapy onychomycosis . 5 . Subjects unwilling refrain use nail cosmetic clear and/or color nail lacquer screen visit end study . 6 . Subjects undergone specify washout period ( ) follow topical preparation subject require concurrent use follow topical medication : 1 . Topical antifungal apply foot ( include antifungal treatment T. pedis study ) : 4 week 2 . Antiinflammatories , corticosteroid , topical immunomodulators : 2 week 7 . Subjects undergone specify washout period ( ) follow systemic medication subject require concurrent use follow systemic medication : 1 . Corticosteroids ( include intramuscular injection ) : 2 week 2 . Antifungals treatment onychomycosis systemic antifungal know activity dermatophyte : 24 week 3 . Systemic immunomodulators : 4 week 8 . Treatment type cancer within last 6 month . 9 . History significant internal disease . 10 . Subjects medical history current past psoriasis skin and/or nail . 11 . Concurrent lichen planus . 12 . Subjects know allergic test product ( ) components test product ( ) history hypersensitivity allergic reaction study preparation describe Investigator 's Brochure . 13 . Nail anatomic abnormality toe , e.g. , genetic nail disorder , primentary disorder , onychogryphosis , trauma nail ( ) treat . 14 . AIDS AIDS relate complex . 15 . History street drug alcohol abuse . 16 . Any subject able meet study attendance requirement . 17 . Subjects participate trial investigational drug device within 60 day prior enrollment participation research study concurrent study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Onychomycosis</keyword>
	<keyword>Fungal Nail</keyword>
</DOC>